These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16820297)

  • 1. Shape-shifting serpins--advantages of a mobile mechanism.
    Huntington JA
    Trends Biochem Sci; 2006 Aug; 31(8):427-35. PubMed ID: 16820297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.
    Baglin TP; Carrell RW; Church FC; Esmon CT; Huntington JA
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11079-84. PubMed ID: 12169660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do dysfunctional serpins tell us about molecular mobility and disease?
    Stein PE; Carrell RW
    Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin inhibition by the serpins.
    Huntington JA
    J Thromb Haemost; 2013 Jun; 11 Suppl 1():254-64. PubMed ID: 23809129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpins: the uncut version.
    Goldsmith EJ; Mottonen J
    Structure; 1994 Apr; 2(4):241-4. PubMed ID: 8087550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How serpins change their fold for better and for worse.
    Carrell RW; Huntington JA
    Biochem Soc Symp; 2003; (70):163-78. PubMed ID: 14587291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
    Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serpin structure, function and dysfunction.
    Huntington JA
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():26-34. PubMed ID: 21781239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological implications of a 3 A structure of dimeric antithrombin.
    Carrell RW; Stein PE; Fermi G; Wardell MR
    Structure; 1994 Apr; 2(4):257-70. PubMed ID: 8087553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.
    Corral J; Aznar J; Gonzalez-Conejero R; Villa P; Miñano A; Vayá A; Carrell RW; Huntington JA; Vicente V
    Circulation; 2004 Sep; 110(10):1303-7. PubMed ID: 15337701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serpins. A mechanistic class of their own.
    Stone SR; Whisstock JC; Bottomley SP; Hopkins PC
    Adv Exp Med Biol; 1997; 425():5-15. PubMed ID: 9433485
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
    Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
    Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes in serpins: II. The mechanism of activation of antithrombin by heparin.
    Whisstock JC; Pike RN; Jin L; Skinner R; Pei XY; Carrell RW; Lesk AM
    J Mol Biol; 2000 Sep; 301(5):1287-305. PubMed ID: 10966821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.